HPV Test
If every woman in the world received adequate health care, almost none would die of cervical cancer. Effective treatments exist for pre-cancerous conditions and for cervical cancer that is diagnosed at an early stage.
By giving Roche, the company that makes the HPV test, the okay to market it to use alone to screen for cervical cancer, the FDA is exposing women to unnecessary health risks and opening the door to a change in medical practice that will abandon evidence-based guidelines and drive up costs. Why would the FDA approve an unsafe use of a test?